← FDA Drug Approvals (Drugs@FDA)

APREMILAST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA · Approved 2023-07-26

Drug application

FDA Application #

ANDA211878

Application type

Abbreviated New Drug Application (Generic)

Brand name

APREMILAST

Generic name

Apremilast

Active ingredients

APREMILAST

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ANNORA

First approval

2023-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown